Biogen Inc. 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 4:48 pm Sale | 2024-10-30 | 13G | Denali Therapeutics Inc. DNLI | BIOGEN INC. BIIB | 7,155,243 4.970% | -5,596,122 (-43.89%) | Filing |
| 2024-02-12 7:07 pm Sale | 2023-12-31 | 13G | Denali Therapeutics Inc. DNLI | BIOGEN INC. BIIB | 12,751,365 9.230% | -558,878 (-4.20%) | Filing |
| 2020-09-28 4:11 pm Purchase | 2020-09-22 | 13G | Denali Therapeutics Inc. DNLI | BIOGEN INC. BIIB | 13,310,243 11.160% | 13,310,243 (New Position) | Filing |